Table 3.
Laboratory findings.
| Parameter | Total (n = 150) |
Survivors (n = 50) |
Non-Survivors (n = 100) |
p Value |
|---|---|---|---|---|
| White blood cell count, ×109/L | 0.002 | |||
| <4 | 12 (8%) | 6 (12%) | 6 (6%) | |
| 4–10 | 87 (58%) | 35 (70%) | 52 (52%) | |
| >10 | 51 (34%) | 9 (18%) | 42 (42%) | |
| Neutrophil to lymphocyte ratio | 8.3 | 7.7 | 8.4 | 0.022 |
| Platelet count, ×109/L | 177 | 169 | 187 | 0.419 |
| <150 | 102 (68%) | 38 (76%) | 64 (64%) | |
| Hemoglobin, g/dl | 12 | 13 | 12 | 0.026 |
| <12 | 71 (47.3%) | 28 (56%) | 43 (43%) | |
| C-reactive protein, mg/L | 95.5 | 102 | 93 | 0.893 |
| >5 | 144 (96%) | 50 (100%) | 94 (94%) | |
| D-dimer, mg/L | 0.8 | 0.4 | 1.7 | <0.001 |
| >0.5 | 98 (63.5%) | 21 (42%) | 77 (77%) | |
| Interleukin-6, pg/mL | 102 | 87 | 124 | 0.005 |
| >1.8 | 150 (100%) | 50 (100%) | 100 (100%) | |
| Ferritin, ng/mL | 568 | 471.5 | 682 | <0.001 |
| >350 | 126 (84%) | 35 (70%) | 85 (85%) | |
| Lactate dehydrogenase, | 430 | 404.5 | 445 | 0.085 |
| >430 U/L | 75 (50%) | 19 (38%) | 56 (56%) | |
| Aspartate aminotransferase, U/L | 43 | 42 | 43 | 0.203 |
| >37 | 94 (62.7%) | 32 (64%) | 62 (62%) | |
| Alanine aminotransferase, U/L | 38.5 | 41 | 38 | 0.193 |
| >40 | 74 (49.3%) | 27 (54%) | 46 (46%) | |
| Total bilirubin, mg/dl | 0.8 | 0.7 | 0.8 | 0.227 |
| >1 | 49 (32.7%) | 12 (24%) | 37 (37%) | |
| Creatinine, mg/dl | 0.9 | 0.9 | 1 | 0.011 |
| >1.1 | 48 (32%) | 11 (22%) | 37 (37%) | |
| Urea, mg/dl | 56 | 44 | 62.5 | <0.01 |
| >50 | 93 (62%) | 18 (36%) | 75 (75%) | |
| Blood sugar, mg/dL | 137.5 | 137 | 140.5 | 0.973 |
| >115 | 112 (74.7%) | 40 (80%) | 72 (72%) | |
| INR | 1.1 | 1.1 | 1.1 | 0.011 |
| >1.2 | 36 (24%) | 4 (8%) | 32 (32%) | |
| Imaging findings | ||||
| Ground-glass opacities | 103 (68.7%) | 30 (60%) | 73 (73%) | 0.121 |
| Focal pulmonary infiltration | 31 (20.7%) | 16 (32%) | 15 (15%) | 0.028 |
| Diffuse andbilateral pulmonary infiltration | 50 (33.3%) | 7 (14%) | 43 (43%) | <0.001 |